Antibody treatments clear amyloid protein from patients’ brains, slowing the progression of their disease but potentially inducing deadly swelling.

Read this story here.

<p>Antibody treatments clear amyloid protein from patients’ brains, slowing the progression of their disease but potentially inducing deadly swelling.</p>
<p>Read this story <a href="https://www.wired.com/story/alzheimers-drugs-benefits-risks-lecanemab-donanemab/">here</a>.</p>

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Advertisement